Cell line · CVCL_1356
KYSE-70
Cancer cell line, Homo sapiens. Esophageal squamous cell carcinoma. 43 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. KYSE-70. Cell lines, record CVCL_1356. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1356
On this page
Cell line
As Cellosaurus gives it.
- Name
- KYSE-70
- Accession
- CVCL_1356
- RRID
- RRID:CVCL_1356
- Synonyms
- KYSE 70, KYSE70, Kyse70, KY70
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 77Y
- Category
- Cancer cell line
- Diseases
- Esophageal squamous cell carcinoma (NCIt C4024); Squamous cell carcinoma of the esophagus (ORDO Orphanet_99977)
- Derived from
- Esophagus (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | TP53 mutation indicated as c.750_751insC in PubMed=8575860. |
Source Cellosaurus
Papers43
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| A First-in-Class LZK Inhibitor Suppresses Tumor Growth and Potentiates EGFR and PI3K Pathway Blockade in Head and Neck and Esophageal Cancers. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Suppression of AKT Activation through LZK Inhibition Limits Tumor Growth in Esophageal and Head and Neck Cancers. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting VEGF signaling and stromal remodeling enhances chemoimmunotherapy efficacy in esophageal cancer. | J Immunother Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| USP5 regulates purine metabolism and represents a therapeutic target in esophageal cancer. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PDIA6 promotes the cell proliferation of ESCC by enhancing the disulfide bond formation in TRAF4. | Cell Mol Biol Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Circulating GPNMB-Based Multimodal Model Integrates Tumor-Immune Crosstalk to Predict Immunotherapy Response in Esophageal Cancer. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Patient-derived organoid xenografts model esophageal cancer cachexia and enable assessment of anti-inflammatory drug repositioning. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Clinofibrate Disrupts the SNORA80B/YTHDC1-Driven M6A Modification to Suppress Cholesterol Metabolism and Cisplatin Resistance in ESCC. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CRISPR/Cas9 Screening Highlights PFKFB3 Gene as a Major Contributor to 5-Fluorouracil Resistance in Esophageal Cancer. | Cancers (Basel) | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 43
See all 43 papersRelatives0
None in this release.
Cell banks3
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1356
GET https://conductscience.org/api/cell-lines/v1/CVCL_1356/papers?page=2